We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Drug Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Kim Thomas Cruse
Kim Thomas Cruse
Products
PRODUCTS
IDT Biologika Gmbh
Kim Thomas Cruse
and
Victoria A. Wagoner
Price:
$117.00
View
Gilead Sciences, Inc.
Kim Thomas Cruse
and
Carl Lee
Price:
$117.00
View
Anchen Pharmaceuticals, Inc.
Kim Thomas Cruse
and
Carla J. Lundi
Price:
$117.00
View
Alliance Medical Products, Inc.
Teresa T. Cain
,
Kim Thomas Cruse
,
Carla J. Lundi
, and
Marcus F. Yambot
Price:
$117.00
View
Watson Laboratories, Inc.
Kim Thomas Cruse
,
John A. Gonzalez
, and
Carla J. Lundi
Price:
$117.00
View
Teva Parenteral Medicines, Inc.
Kim Thomas Cruse
,
Virgilio F. Facio
,
Jennifer M. Gogley
,
Carla J. Lundi
,
Joey V. Quitania
, and
Comyar Shoghi
Price:
$117.00
View
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
Regeneron Begins Phase 3 Trial of Antibody Cocktail for COVID-19
Becton Dickinson Earns EUA for Point-of-Care COVID-19 Test
Novavax Nabs $1.6 Billion Warp Speed Contract for COVID-19 Vaccine
FDA Warns of False Positive Risks Associated with COVID-19 Test
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
